Albania vs Poland: The number of people with susceptibility test result for rifampicin
Albania
91.67
in 2021
Poland
91.55
in 2021
Albania rank
64th
Poland rank
65th
The number of people with susceptibility test result for rifampicin over time
- Albania
- Poland
How they compare
Albania currently reports 91.67 against 91.55 in Poland, a difference of 0.12.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Poland ahead.
Albania ranks 64th and Poland ranks 65th of 146 countries.
Across the 2 decades both report, Albania averaged higher in 1 and Poland in 1.
Head to head by decade
| Decade | Albania | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 25.83 | 89.97 | 64.14 | Poland |
| 2020s | 92.48 | 90.9 | 1.58 | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Albania or Poland?
- Albania, at 91.67 against 91.55 in Poland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Albania and Poland?
- 0.12, with Albania ahead.
- How many years of comparable data are there for Albania and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Albania and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Albania ranks 64th and Poland ranks 65th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.